YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29 - Wikidata - awgldk - TriplyDB

YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29

YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29

http://www.wikidata.org/entity/Q39246531

about

The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials YAP-Mediated Mechanotransduction in Skeletal Muscle Emerging role of Hippo pathway in gastric and other gastrointestinal cancers A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas An intronic microRNA links Rb/E2F and EGFR signaling Genome-wide analysis of miRNA signature in the APPswe/PS1ΔE9 mouse model of alzheimer's disease A model of muscle atrophy based on live microscopy of muscle remodelling in Drosophila metamorphosis.Scaling the Drosophila Wing: TOR-Dependent Target Gene Access by the Hippo Pathway Transducer Yorkie Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up YAP and TAZ: a nexus for Hippo signaling and beyond miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival What do mechanotransduction, Hippo, Wnt, and TGFβ have in common? YAP and TAZ as key orchestrating molecules in ocular health and disease.The role of the Hippo pathway in human disease and tumorigenesis The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer.MicroRNAs are critical regulators of tuberous sclerosis complex and mTORC1 activity in the size control of the Xenopus kidney.HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway.The hippo pathway in heart development, regeneration, and diseases Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance.Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment Expression of microRNAs is essential for arterial myogenic tone and pressure-induced activation of the PI3-kinase/Akt pathway.The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.Pathway analysis of microRNA expression profile during murine osteoclastogenesis Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.The PI3K pathway balances self-renewal and differentiation of nephron progenitor cells through β-catenin signaling.NDR functions as a physiological YAP1 kinase in the intestinal epithelium.Yes-Associated Protein is up-regulated by mechanical overload and is sufficient to induce skeletal muscle hypertrophy The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis.A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness.A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis.The emerging roles of YAP and TAZ in cancer PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients.YAP is a critical oncogene in human cholangiocarcinoma Exploiting Expression of Hippo Effector, Yap, for Expansion of Functional Islet Mass.Cancer stem cells and cell size: A causal link?The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions

P2860

Q26744308-3BC2EC41-3F48-4C1F-8B5B-5BC1A613165D Q26751155-FFE52254-C087-4490-8FFD-3495DC037D63 Q26766774-677FBBBE-2D49-4570-8E0B-0B26D1A38848 Q26774473-B85BF67D-4C28-4535-B77D-E6352363A42C Q26782842-DD181C7A-DA50-4231-9AC0-BD8B1C48B910 Q27314824-7F0A7244-63B3-4F2C-8931-DFC652E6CCC5 Q27320372-9DF83C63-76C1-45B5-B6A4-85BD744BED7F Q27334997-3A5C1BDB-8856-4C92-9865-F9A4A70A725E Q27346588-A2290DF2-1744-489B-B947-335B4BF8B90D Q28083996-D92AB93C-4195-430B-9D0A-9B589A001536 Q28085636-EA92BF5D-9D7E-4D23-AD34-0FA8688340C2 Q28579456-8DA43AB1-A7AB-4C66-87BB-73E6667001C4 Q30429628-A440BF9E-CF43-4469-A6D2-F8F36459D19B Q30433413-68E793D3-F517-4C2E-9A20-D24933B4078F Q33588163-47DF74FF-B04E-4DB8-B1D7-DBBF6DBA73F3 Q33674749-951719D1-2ED1-4E6C-A8F5-FDC94D5BF556 Q34115364-F262A1D6-533D-442C-B8F7-99165272ABCA Q34470968-909D0999-A80D-49B3-AC48-2667BAA88138 Q34974398-47160C0F-04C8-4EF5-84D2-6FE2B0913467 Q35003114-F7105EC7-8874-4FC9-9CD8-4C6D85E05BB3 Q35043317-020B805F-6D37-48E8-81E4-0AB8C0A30EFA Q35214708-1DD09820-5971-4C39-B1EB-4BA3CF9AE4D9 Q35252690-53E83581-380B-4B50-B1CE-2FD196499957 Q35451755-58F9D1BF-3A65-4375-878F-C5404A61F42B Q35453913-4642763A-C6CC-4813-BECD-D2E23766E9EB Q35591698-6B1E0105-D5AD-435B-BD68-8F4769E4C30C Q35639688-29EBD73F-160D-4E6B-B86E-6AA5E6B97C32 Q35685257-1CE5F1E0-CC34-496A-93F1-5FE3E120ACAB Q35742436-3621A606-25B7-49E8-A57D-B3A159C78E28 Q35742770-20B6BDC8-E340-4E43-8F72-EB37B9E113DC Q35832201-A635DB05-1D4C-4EA4-834C-2CC14E9DD643 Q35925760-ABCDF222-55FB-4DFF-A0E2-178876AAB07A Q36027005-E3BF0C0F-2689-4EA6-AD6B-468E7E903848 Q36035567-00721D0B-DDAD-4156-B8AD-79301D90FAD2 Q36096004-B2F7C43A-C300-4B6C-90B0-3FAC26088FD2 Q36232005-E5A1BBD6-7ED2-40D1-BEC1-6DA7A057A7A9 Q36232970-2FAFD30B-8871-4F02-B996-D9916A9E146E Q36296444-A895622E-7BB5-4ECF-9677-983B08F6F1DB Q36350091-0196A498-B690-4400-9435-0D5AE5E04505 Q36370996-9E1C2A9A-ED8F-416A-B381-9E0B358D76CB

P2860

YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29

http://www.wikidata.org/entity/Q39246531

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

YAP mediates crosstalk between the Hippo and PI

@nl

YAP mediates crosstalk between ...... by suppressing PTEN via miR-29

@en

type

label

YAP mediates crosstalk between the Hippo and PI

@nl

YAP mediates crosstalk between ...... by suppressing PTEN via miR-29

@en

prefLabel

YAP mediates crosstalk between the Hippo and PI

@nl

YAP mediates crosstalk between ...... by suppressing PTEN via miR-29

@en

P1433

Q39246531-0382FAC2-EEA7-409F-ACEB-CE226532E8B3

P1476

Q39246531-57470FAD-7868-47A3-80EC-9A2890D7123C

P2093

Q39246531-250B9CF0-4154-4AAF-9780-93F98C390128

Q39246531-27000645-022C-40FE-9F6D-970FBFDCDEF9

Q39246531-60742B9E-6F11-41DC-82E9-9C9D0A088932

Q39246531-7852B3D4-2FBE-4D88-891A-59C80CBB2E38

Q39246531-8278FDD0-94D0-44BE-82DB-C68875A7CA87

Q39246531-87D562AD-6C2C-40DC-8FF1-89EEF7296075

Q39246531-C2DB30A8-51FC-4073-99FA-82974E01C3BA

Q39246531-E83F37B6-22CA-4052-8E94-1F26DD57B9DA

P2860

Q39246531-082E7265-5348-4161-9141-FAF07BC7D9E3

Q39246531-114E32E7-2D8A-43F9-8DA5-ABC1ADE0BBFB

Q39246531-18B1A769-A4C0-42D2-957B-B03D9DC3D9DA

Q39246531-28262AD2-383A-4CC2-872E-6316717106CF

Q39246531-368891AE-B54D-435E-B199-074C8C491903

Q39246531-3CF56BF2-AAF0-4284-82CE-D75BAAB461EF

Q39246531-3EC8C46D-6D01-4FF4-AACD-84A96B23E739

Q39246531-53FB7C69-B950-4F83-947B-5283066FD02D

Q39246531-5ABC67A0-6432-4DFA-98CC-4216C1CF6389

Q39246531-5DC8A132-69ED-4800-88A3-1847EF782E3A

P2888

Q39246531-49CBF55D-CA79-4BF0-9255-62B221223C2B

P304

Q39246531-345C325D-4C9F-451A-862E-043E5B92C4FC

P31

Q39246531-96349E11-8D53-4774-B5AE-D7968C6DE6EF

P356

Q39246531-381907BA-218D-4EF9-A290-2BD1B778CFE7

P433

Q39246531-DB330239-6257-4F2A-BE96-B4E9E74A514C

P478

Q39246531-0CCCD643-F7FF-4248-BF91-AF4613A19058

P50

Q39246531-4E1AA351-B19C-449D-B1F2-1BC70CE51188

Q39246531-88865C48-8E03-4AC3-8721-B79B8248947C

P577

Q39246531-58C55DFF-A8D6-4FA0-98BE-E0CE0886D5BA

P5875

Q39246531-C8AECACC-6C47-4153-96BE-71DAF29CA068

P698

Q39246531-67D8054F-6480-4675-993C-4AD37104C955

P932

Q39246531-428331C3-B40C-4149-8C60-CAFAFF72D17F

P356

P1433

Nature Cell Biology

P1476

YAP mediates crosstalk between ...... by suppressing PTEN via miR-29

@en

P2093

Fernando D Camargo

http://www.w3.org/2001/XMLSchema#string

Harihar Basnet

http://www.w3.org/2001/XMLSchema#string

Julien Fitamant

http://www.w3.org/2001/XMLSchema#string

Karen Tumaneng

http://www.w3.org/2001/XMLSchema#string

Karin Schlegelmilch

http://www.w3.org/2001/XMLSchema#string

Kun-Liang Guan

http://www.w3.org/2001/XMLSchema#string

Nabeel Bardeesy

http://www.w3.org/2001/XMLSchema#string

Navin Mahadevan

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of the PTEN tail regulates protein stability and function

Yap1 acts downstream of α-catenin to control epidermal proliferation

Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery

Tumor suppressor LATS1 is a negative regulator of oncogene YAP

TEAD mediates YAP-dependent gene induction and growth control

A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator.

Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model

The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1

P2888

P304

1322-1329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCB2615

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233395580

http://www.w3.org/2001/XMLSchema#string

P698

23143395

http://www.w3.org/2001/XMLSchema#string

P932

4019071

http://www.w3.org/2001/XMLSchema#string